Cancer Care Ontario | Cancer Care Ontario

12 Results

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2020

Status: Current
ID: PET 2020-1
Version: N/A

Nov 2020

Guidelines and Advice

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Status: Archived
ID: CED 10

Sep 2008

Guidelines and Advice

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Status: Archived
ID: CED 9

Aug 2008

Guidelines and Advice

The Use of Epidermal Growth Factor Receptor Inhibitors in Advanced Colorectal Cancer

Status: Archived
ID: CED 8

Jul 2008

Guidelines and Advice

Sorafenib for Advanced Hepatocellular Carcinoma

Status: Archived
ID: CED 7

Feb 2008

Guidelines and Advice

Management of Stage I Nonseminomatous Testicular Cancer

Status: Archived
ID: 3-19

Feb 2008

Guidelines and Advice

Provider-Patient Communication

Status: Education and Information
ID: 19-2

Mar 2008

Guidelines and Advice

Cancer-Related Pain Management: a Report of Evidence-based Recommendations to Guide Practice

Status: Archived
ID: 16-2

Mar 2008

Guidelines and Advice

Treatment of Acute Myeloid Leukemia in Older Patients

Status: Archived
ID: 6-14

Dec 2008

Guidelines and Advice

The Management of Malignant Thrombocytosis in Philadelphia Chromosome-Negative Myeloproliferative Disease

Status: Archived
ID: 6-9

Jan 2008

Statistical Reports

Ontario Cancer Screening Performance Report, 2020

*/ For the most recent data, refer to the Ontario Cancer Screening Performance Report 2023. Effective cancer screening through organized...

Nov 2020